Premium
P1–010: Chronic treatment with scyllo‐inositol reduces brain myo‐inositol levels and enhances performance in a rat model of social withdrawal
Author(s) -
Shughrue Paul,
Quinn Kevin,
Brigham Elizabeth,
Gallager Ian,
Abushakra Susan,
Kinney Gene
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.230
Subject(s) - apathy , sniffing , medicine , psychology , pharmacology , endocrinology , disease , neuroscience
P1-010 CHRONIC TREATMENT WITH SCYLLOINOSITOL REDUCES BRAIN MYO-INOSITOL LEVELS AND ENHANCES PERFORMANCE IN A RAT MODEL OF SOCIALWITHDRAWAL Paul Shughrue, Kevin Quinn, Elizabeth Brigham, Ian Gallager, Susan Abushakra, Gene Kinney, Elan Pharmaceuticals, South San Francisco, California, United States; Elan Pharmaceuticals, South San Francisco, California, United States. Contact e-mail: paul.shughrue@ prothena.com